Literature DB >> 22344318

Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation.

Maria Antonia Serra-Pinheiro1, Evandro S F Coutinho, Isabella S Souza, Camilla Pinna, Dídia Fortes, Catia Araújo, Claudia M Szobot, Luis A Rohde, Paulo Mattos.   

Abstract

OBJECTIVE: To investigate meta-analytically if the association between ADHD and illicit substance use (ISU) is maintained when controlling for conduct disorder/oppositional-defiant disorder (CD/ODD).
METHOD: A systematic literature review was conducted through Medline from 1980 to 2008. Data extracted and selections made by one author were reviewed by another.
RESULTS: Fifteen articles presented odds ratios (ORs) for the development of ISU in individuals with ADHD controlling for CD/ODD. In total, the study covered results for more than 1,000 individuals. The combined OR for studies that included in their analysis exclusively ISU was 1.35 (0.90-2.03), p = .15, heterogeneity = 55%. Lack of control for socioeconomic status was related with a weaker association between ADHD and ISU.
CONCLUSION: The existing data do not indicate that ADHD increases the risk of ISU beyond the effects of CD/ODD. However, the combination of all existing data is limited in power to detect a small increase in chance.

Entities:  

Keywords:  ADHD; comorbidity; conduct disorder; drug; substance

Mesh:

Year:  2012        PMID: 22344318     DOI: 10.1177/1087054711435362

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  8 in total

1.  Reward Processing in Drug-Naive Youth with Various Levels of Risk for Substance Use Disorders: A Pilot Study.

Authors:  Iliyan Ivanov; Kurt Schulz; Xiaobo Li; Jeffrey Newcorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-06-10       Impact factor: 2.576

2.  Externalizing disorders and substance use: empirically derived subtypes in a population-based sample of adults.

Authors:  Stephanie Rodgers; Mario Müller; Wulf Rössler; Enrique Castelao; Martin Preisig; Vladeta Ajdacic-Gross
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-07       Impact factor: 4.328

3.  In-the-Moment Drinking Characteristics: An Examination Across Attention-Deficit/Hyperactivity Disorder History and Race.

Authors:  Kirsten M P McKone; Traci M Kennedy; Thomas M Piasecki; Brooke S G Molina; Sarah L Pedersen
Journal:  Alcohol Clin Exp Res       Date:  2019-05-06       Impact factor: 3.455

4.  Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.

Authors:  N Estévez; M Dey; D Eich-Höchli; S Foster; G Gmel; M Mohler-Kuo
Journal:  Epidemiol Psychiatr Sci       Date:  2015-05-20       Impact factor: 6.892

Review 5.  Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.

Authors:  José Pérez de los Cobos; Núria Siñol; Víctor Pérez; Joan Trujols
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

6.  Psychiatric Diagnoses Differ Considerably in Their Associations With Alcohol/Drug-Related Problems Among Adolescents. A Norwegian Population-Based Survey Linked With National Patient Registry Data.

Authors:  Ove Heradstveit; Jens Christoffer Skogen; Jørn Hetland; Robert Stewart; Mari Hysing
Journal:  Front Psychol       Date:  2019-05-08

7.  Mediating and Moderating Role of Depression, Conduct Disorder or Attention-Deficit/Hyperactivity Disorder in Developing Adolescent Substance Use Disorders: A Population-Based Study.

Authors:  Kouichi Yoshimasu; William J Barbaresi; Robert C Colligan; Robert G Voigt; Amy L Weaver; Slavica K Katusic
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

8.  Substance use in young adults with ADHD: Comorbidity and symptoms of inattention and hyperactivity/impulsivity.

Authors:  Ana Miranda; Carla Colomer; Carmen Berenguer; Rocio Roselló; Belén Roselló
Journal:  Int J Clin Health Psychol       Date:  2015-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.